In EC, FTO, along with YTHDF1 upregulates the expression of 17beta‐hydroxysteroid dehydrogenase 11 (HSD17B11), thereby promoting the formation of lipid droplets in EC cells and cancer development, which is associated with a poor prognosis for patients with EC.412. This evidence concerns the gene FTO and cancer.